Boule Diagnostics Past Earnings Performance

Past criteria checks 1/6

Boule Diagnostics's earnings have been declining at an average annual rate of -33%, while the Medical Equipment industry saw earnings declining at 9.5% annually. Revenues have been growing at an average rate of 1.8% per year. Boule Diagnostics's return on equity is 10.2%, and it has net margins of 6.1%.

Key information

-33.0%

Earnings growth rate

-33.8%

EPS growth rate

Medical Equipment Industry Growth	-9.5%
Revenue growth rate	1.8%
Return on equity	10.2%
Net Margin	6.1%
Next Earnings Update	10 Nov 2022

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Boule Diagnostics makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BATS-CHIXE:BOULS Revenue, expenses and earnings (SEK Millions)
Date	Revenue	Earnings	G+A Expenses	R&D Expenses
30 Jun 22	525	32	131	48
31 Mar 22	495	28	126	45
31 Dec 21	463	23	120	43
30 Sep 21	416	-27	115	42
30 Jun 21	403	-13	113	42
31 Mar 21	383	-55	107	44
31 Dec 20	400	-48	111	43
30 Sep 20	437	-8	116	41
30 Jun 20	470	-8	119	37
31 Mar 20	499	35	130	32
31 Dec 19	499	38	128	30
30 Sep 19	476	32	126	31
30 Jun 19	456	21	124	33
31 Mar 19	444	36	115	33
31 Dec 18	424	41	110	29
30 Sep 18	425	48	111	24
30 Jun 18	424	60	112	25
31 Mar 18	421	43	111	27
31 Dec 17	428	37	116	32
30 Sep 17	422	31	114	38
30 Jun 17	421	28	110	38
31 Mar 17	419	38	109	38
31 Dec 16	397	36	105	37
30 Sep 16	383	36	97	40
30 Jun 16	364	22	96	42
31 Mar 16	341	15	93	42
31 Dec 15	331	15	89	40

Quality Earnings: BOULS has a high level of non-cash earnings.

Growing Profit Margin: BOULS became profitable in the past.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: BOULS's earnings have declined by 33% per year over the past 5 years.

Accelerating Growth: BOULS has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: BOULS has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-12.2%).

Return on Equity

High ROE: BOULS's Return on Equity (10.2%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2022/10/29 18:46
End of Day Share Price	2022/08/01 00:00
Earnings	2022/06/30
Annual Earnings	2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Boule Diagnostics AB (publ) is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Jakob Lembke	ABG Sundal Collier Sponsored
null null	ABG Sundal Collier Sponsored
Christian Lee	Pareto Securities